4321 - 4330 of 9039 Results
Title
Year
-
OPENTitle: Cross‐validation of optimized composites for preclinical Alzheimer's diseaseJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 3Issue #: 1Start Page: 123End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.trci.2016.12.001Best OA location URL: https://doi.org/10.1016/j.trci.2016.12.001Citation Count: 28
- MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat model2013RESTRICTEDTitle: MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat modelJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 553Issue #:Start Page: 153End Page: 158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2013.08.001Citation Count: 65
- Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's disease2016RESTRICTEDTitle: Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 417End Page: 421Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26483Citation Count: 43
-
OPENTitle: GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson's Disease SusceptibilityJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 3Start Page: 761End Page: 766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.70127Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70127Citation Count: 0
-
OPENTitle: Insights from a cross-sectional population-based study of 10,929 Australians living with Parkinson's disease: risk factors, comorbidities, and sex differencesJournal Name: The Lancet Regional Health - Western PacificPublisher: Elsevier BVVol: 68Issue #:Start Page: 101816End Page: 101816Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.lanwpc.2026.101816Best OA location URL: https://doi.org/10.1016/j.lanwpc.2026.101816Citation Count: 1
-
OPENTitle: Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser129 in Biological SamplesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 7Start Page: 1238End Page: 1248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.2c00676Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.2c00676Citation Count: 30
- Transplant and risk of Parkinson disease2019RESTRICTEDTitle: Transplant and risk of Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 149End Page: 155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.013Citation Count: 8
- Exploring the neuroprotective potential of immunosuppressants in Parkinson's disease2025RESTRICTEDTitle: Exploring the neuroprotective potential of immunosuppressants in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 132Issue #:Start Page: 107294End Page: 107294Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107294Citation Count: 2
-
OPENTitle: Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patientsJournal Name: Toxicology ReportsPublisher: Elsevier BVVol: 4Issue #:Start Page: 188End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.toxrep.2017.03.005Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S221475001730015X-fx1_lrg.jpgCitation Count: 29
- The impact of non-motor symptoms on physical activity in Parkinson’s disease2025OPENTitle: The impact of non-motor symptoms on physical activity in Parkinson’s diseaseJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/17582024.2025.2607694Citation Count: 1
